Optimizing Investments in the Kyrgyz Republic’s HIV Response
This report summarizes the findings of an allocative efficiency analysis on the Kyrgyz Republic`s national HIV epidemic and response conducted in 2014-15. The report addresses core questions for resource allocation such ‘How can HIV funding be opti...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Report |
| Language: | English en_US |
| Published: |
World Bank, Washington, DC
2016
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/264481477977075763/Optimizing-investments-in-the-Kyrgyz-Republic-s-HIV-response http://hdl.handle.net/10986/25377 |
| Summary: | This report summarizes the findings of
an allocative efficiency analysis on the Kyrgyz Republic`s
national HIV epidemic and response conducted in 2014-15. The
report addresses core questions for resource allocation such
‘How can HIV funding be optimally allocated to the
combination of HIV response interventions that will yield
the highest impact?’ or ‘What level of investment is
required to achieve national targets, if we allocate
resources optimally?’. The report describes epidemiological
and HIV financing trends as well as identifies
sub-populations, which are most affected by the epidemic.
Based on this information, the optimized mix of
interventions for minimizing new HIV infections and deaths
is identified using mathematical modelling techniques.
Required investments into programs for key populations and
antiretroviral treatment are established and translated into
policy recommendations. The Kyrgyz Republic’s HIV epidemic
is transitioning from an early concentrated epidemic among
people who inject drugs (PWID) into an advanced concentrated
HIV epidemic with continued transmission among PWID, but an
increasing share of sexual transmission to female partners
of PWID and among men who have sex with men (MSM). The
Optima model projected that, with current spending, the
estimated 1,000 annual new infections in 2014 will increase
to 1,100, and estimated deaths from 400 in 2014 to 600
deaths per year on average, over 2015-20. |
|---|